Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cryptococcal Meningitis Reported With Fingolimod Treatment: Case Series.
Del Poeta M, Ward BJ, Greenberg B, Hemmer B, Cree BAC, Komatireddy S, Mishra J, Sullivan R, Kilaru A, Moore A, Hach T, Berger JR. Del Poeta M, et al. Among authors: kilaru a. Neurol Neuroimmunol Neuroinflamm. 2022 Mar 22;9(3):e1156. doi: 10.1212/NXI.0000000000001156. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35318259 Free PMC article.
COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients: Case Series.
Sullivan R, Kilaru A, Hemmer B, Campbell Cree BA, Greenberg BM, Kundu U, Hach T, DeLasHeras V, Ward BJ, Berger J. Sullivan R, et al. Among authors: kilaru a. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 30;9(1):e1092. doi: 10.1212/NXI.0000000000001092. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34848501 Free PMC article.
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.
Gold R, Piani-Meier D, Kappos L, Bar-Or A, Vermersch P, Giovannoni G, Fox RJ, Arnold DL, Benedict RHB, Penner IK, Rouyrre N, Kilaru A, Karlsson G, Ritter S, Dahlke F, Hach T, Cree BAC. Gold R, et al. Among authors: kilaru a. J Neurol. 2022 Sep;269(9):5093-5104. doi: 10.1007/s00415-022-11166-z. Epub 2022 May 31. J Neurol. 2022. PMID: 35639197 Free PMC article. Clinical Trial.
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
Cree BA, Arnold DL, Fox RJ, Gold R, Vermersch P, Benedict RH, Bar-Or A, Piani-Meier D, Rouyrre N, Ritter S, Kilaru A, Karlsson G, Giovannoni G, Kappos L. Cree BA, et al. Among authors: kilaru a. Mult Scler. 2022 Sep;28(10):1591-1605. doi: 10.1177/13524585221083194. Epub 2022 Apr 5. Mult Scler. 2022. PMID: 35380078 Free PMC article.
Eligibility of emergency department patients for public benefit programs.
Harrison J, McDermott G, Dixon EL, Mehta M, Haider A, Rareshide C, Southwick L, Agarwal AK, Merchant RM, Kilaru AS. Harrison J, et al. Among authors: kilaru as. Acad Emerg Med. 2024 Mar 25. doi: 10.1111/acem.14870. Online ahead of print. Acad Emerg Med. 2024. PMID: 38528799 No abstract available.
9,10-KODA, an α-ketol produced by the tonoplast-localized 9-lipoxygenase ZmLOX5, plays a signaling role in maize defense against insect herbivory.
Yuan P, Borrego E, Park YS, Gorman Z, Huang PC, Tolley J, Christensen SA, Blanford J, Kilaru A, Meeley R, Koiwa H, Vidal S, Huffaker A, Schmelz E, Kolomiets MV. Yuan P, et al. Among authors: kilaru a. Mol Plant. 2023 Aug 7;16(8):1283-1303. doi: 10.1016/j.molp.2023.07.003. Epub 2023 Jul 11. Mol Plant. 2023. PMID: 37434355
92 results